1887

Abstract

Pneumococcal disease remains an important cause of invasive and non-invasive disease in Scotland and elsewhere. The Scottish Meningococcus and Pneumococcus Reference Laboratory receives isolates of from diagnostic laboratories around Scotland. Here, the serogroups/types and antibiotic-susceptibility patterns of invasive isolates received between 1999 and 2002 are described. There were a total of 1741 invasive isolates received, the most common serogroups/types being 14 (19.8 %), 9 (10.2 %), 6 (8.3 %), 19 (7.9 %), 23 (7.9 %), 4 (6.5 %), 8 (6.4 %), 3 (5.7 %), 1 (3.8 %), 7 (3.8 %) and 18 (3.4 %). Importantly, serotypes 7 and 8 are not represented in the 7-, 9- and 11-valent pneumococcal conjugate polysaccharide vaccines. There were 67 (3.8 %) isolates considered penicillin non-susceptible, although no penicillin resistance (MIC ⩾ 0.002 mg ml) was recorded. One hundred and ninety-four (11.1 %) isolates, predominantly of serotype 14, were resistant to erythromycin, and 12 (0.7 %) were resistant to ciprofloxacin. This information provides an important dataset that will prove essential prior to and during the implementation of pneumococcal conjugate vaccines in the UK.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45718-0
2005-04-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/4/JM540403.html?itemId=/content/journal/jmm/10.1099/jmm.0.45718-0&mimeType=html&fmt=ahah

References

  1. Bos, J. M., Rumke, H., Welte, R. & Postma, M. J. ( 2003;). Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands. Clin Ther 25, 2614–2630.[CrossRef]
    [Google Scholar]
  2. Clarke, S. C., Diggle, M. A. & Edwards, G. F. ( 2001;). Surveillance of pneumococcal disease in Scotland. SCIEH Weekly Report 35, 2. 2.
    [Google Scholar]
  3. Gertz, R. E., Jr, McEllistrem, M. C., Boxrud, D. J. & 8 other authors ( 2003;). Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 41, 4194–4216.[CrossRef]
    [Google Scholar]
  4. Kyaw, M. H., Clarke, S., Edwards, G. F., Jones, I. G. & Campbell, H. ( 2000;). Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiol Infect 125, 561–572.[CrossRef]
    [Google Scholar]
  5. Kyaw, M. H., Jones, I. G. & Campbell, H. ( 2002a;). Prevalence of penicillin non-susceptible invasive pneumococcal disease in the elderly in Scotland, 1992–99. Scand J Infect Dis 34, 559–563.[CrossRef]
    [Google Scholar]
  6. Kyaw, M. H., Clarke, S., Jones, I. G. & Campbell, H. ( 2002b;). Incidence of invasive pneumococcal disease in Scotland, 1988–99. Epidemiol Infect 128, 139–147.
    [Google Scholar]
  7. Kyaw, M. H., Christie, P., Clarke, S. C., Mooney, J. D., Ahmed, S., Jones, I. G. & Campbell, H. ( 2003;). Invasive pneumococcal disease in Scotland, 1999–2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 37, 1283–1291.[CrossRef]
    [Google Scholar]
  8. Mohan, P. V. & Heath, P. T. ( 2001;). Pneumococcal disease in childhood. Hosp Med 62, 406–409.[CrossRef]
    [Google Scholar]
  9. Muhlemann, K., Matter, H. C., Tauber, M. G. & Bodmer, T. ( 2003;). Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998–1999. J Infect Dis 187, 589–596.[CrossRef]
    [Google Scholar]
  10. Obaro, S. & Adegbola, R. ( 2002;). The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol 51, 98–104.
    [Google Scholar]
  11. Skoczynska, A. & Hryniewicz, W. ( 2003;). Genetic relatedness, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae responsible for meningitis in Poland, 1997–2001. Microb Drug Resist 9, 175–182.[CrossRef]
    [Google Scholar]
  12. Smart, L. E. ( 1986;). Serotyping of Streptococcus pneumoniae strains by coagglutination. J Clin Pathol 39, 328–331.[CrossRef]
    [Google Scholar]
  13. Whitney, C. G., Farley, M. M., Hadler, J. & 10 other authors ( 2003;). Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine. N Engl J Med 348, 1737–1746.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45718-0
Loading
/content/journal/jmm/10.1099/jmm.0.45718-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error